Antitumor Activity and Molecular Mechanism of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition

By
Justin.choi
-
0
213
Scientists discuss the advancement of PCSK9 research on its role and underlying mechanisms in tumor development and progression.
[Naunyn-Schmiedebergs Archives of Pharmacology]

Sorry, but the selected Zotpress account can't be found.

Abstract